![](https://investorshub.advfn.com/uicon/77609.png?cb=1485869477)
Friday, December 18, 2020 12:53:05 PM
December 10, 2020
Lisette Hilton
Dustin Sjuts, CCO, Revance, says the company aims to elevate the patient dermal filler experience by emphasizing experience and quality over price.
Consumers price shopping for treatment with one of Revance Therapeutics’ FDA approved Resilient Hyaluronic Acid (RHA) facial fillers might find their online efforts to price-shop providers are stonewalled.
That’s because Revance wants consumers to pick their filler providers based on outcomes and experience, not price.
“We have created a global brand policy that asks that our partners do not advertise the price of RHA to consumers,” says Dustin Sjuts, Revance’s chief commercial officer. “Instead, we partner with experienced aesthetic providers who focus on patient outcomes, creating an elevated patient experience as well as innovation in differentiated products, such as the RHA Collection.”
Revance announced early in 2020 that it had signed a U.S. distribution agreement with TEOXANE SA to become the exclusive commercialization partner for RHA technology. The FDA has approved RHA 2, RHA 3, and RHA 4 for correction of dynamic wrinkles and folds such as nasolabial folds. RHA 1 is in clinical trials, with an anticipated 2021 approval. Revance’s neuromodulator DaxibotulinumtoxinA for Injection (DAXI), which is expected to create a new category of long-lasting neuromodulators lasting an average 24 to 28 weeks, also is awaiting the FDA’s nod.
While Sjuts says he cannot comment on how Revance will handle advertised pricing with still unapproved products, including DAXI, it is the company’s belief that marketing related to its products should focus on innovation and experience rather than price. The select offices that offer RHA fillers can charge what they feel is appropriate and reveal prices to individual patients post-consultation, he says.
Some aesthetic providers advertise price, but some don’t.
Facial plastic surgeon Paul J. Carniol, MD, president of The American Academy of Facial Plastic and Reconstructive Surgery and founder of Carniol Plastic Surgery in Summit, N.J., says it has long been his practice’s policy not to advertise prices. And he realizes that some people who do shop for price might not become patients.
“It is the nature of our office that we do not try to compete on price. We emphasize quality and skills,” Dr. Carniol says. “I think that is an interesting strategy that Revance has. There are certainly consumers that are willing to pay a higher price for filler if they feel they are getting better quality. I think that Revance’s aim is that group.”
https://www.aestheticauthority.com/view/changing-the-injectable-pricing-game
Recent RVNC News
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 08/13/2024 01:29:06 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 08/12/2024 09:18:26 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of Revance Therapeutics, Inc. • PR Newswire (US) • 08/12/2024 07:18:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 01:20:58 PM
- Crown Laboratories and Revance Announce Entry Into Merger Agreement • PR Newswire (US) • 08/12/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 01:00:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:34:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:07:57 PM
- Revance Reports Second Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 08/08/2024 08:05:00 PM
- Revance to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 • Business Wire • 08/01/2024 08:05:00 PM
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/14/2024 08:05:00 PM
- Revance to Participate in Upcoming Investor Conferences • Business Wire • 05/28/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:33:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:08:10 PM
- Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 05/09/2024 08:06:00 PM
- Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia • Business Wire • 05/09/2024 08:05:00 PM
- Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 • Business Wire • 05/02/2024 08:05:00 PM
- Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting • Business Wire • 04/12/2024 12:00:00 PM
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/27/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:33:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:08:05 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/05/2024 10:00:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:34:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:33:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:44:22 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM